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Aims. The purpose of the present study was to evaluate predictors of outcome in primary supratentorial cerebral haemorrhage.
Furthermore, we aimed to develop a prognostic model to predict 30-day fatality.Methods. We retrospectively analyzed a database
of 156 patients with spontaneous supratentorial haemorrhage to explore the relationship between clinical andCT characteristics and
fatal outcome within 30 days using multiple logistic regression analysis. The analyzed factors included volumetric data assessed by
neuropathological and CT volumetry. A second CT scan in survivors or neuropathological ABC/2 volumetry in nonsurvivors was
used along with the baseline CT to assess the growth index of haematoma. Results. Systolic blood pressure, serum potassium and
glucose levels, platelet count, absolute and relative haematoma volumes, and presence and size of intraventricular haemorrhage
statistically significantly predicted the fatal outcome within 30 days. Based on our results we formulated a six-factor scoring
algorithm named SUSPEKT to predict outcome. Conclusions. After validation the SUSPEKT score may be applicable in general
clinical practice for early patient selection to optimize individual management or for assessment of eligibility for treatment trials.
1. Introduction
Spontaneous intracerebral haemorrhage (ICH) accounts for
8% to 14% of all strokes and carries the highest mortality rate
of major stroke subtypes [1]. The pharmacological and surgi-
cal interventions are less efficient than in case of ischaemic
stroke [2]. Half of the mortality occurs within the first 2
days as a result of brain herniation [3]. Thirty-five to 52% of
patients are dead by 1 month and only 20% of patients live
independently at 6 months [4].
Predictors ofmortality and functional outcome have been
studied widely [5–7], but no treatment has shown a proven
benefit so far. Accordingly, comprehensive analysis of the
potential predictive factors of short term fatal outcome is of
great importance. Reviewing the data of ICH patients admit-
ted to the Neurology Department, University of Debrecen
(UD), we retrospectively analyzed the relationship between
clinical and CT characteristics and case fatality at 30 days.
The autopsy rate of our department is more than 90%;
therefore we could incorporate also the results of brain autop-
sies into our analysis.This is a unique opportunity (compared
with similar studies) in the era of declining brain autopsy
rates [8]. Although all of our patients were immediately
investigated by CT or MRI at acute admission (and repeated
if required by the patient’s deteriorating condition), we
also had opportunity to analyze the results of their brain
autopsies, agreeing with the Agency for Healthcare Research
and Quality U.S. Department of Health and Human Services:
“clinical diagnoses, whether obtained from death certificates
or hospital discharge data, contain major inaccuracies com-
pared with autopsy diagnoses” [9].
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Numerous pathological eventsmight occur in the brain of
ICH patients (e.g., enlargement of haemorrhage, secondary
brainstem bleeding) between the first and second imaging
[10] or between the last CT and death. On the other hand,
there are ethical and financial limitations of daily CT/MRI
during the agony phase for estimating the “final” pathological
findings of our patients. So, in our study we combined the
classical in vivo (image-based) volumetric evaluations with
the measurements performed on the same formalin-fixed
brain slices after the death of patients. Taking advantage
of this opportunity, the ABC/2 method was also applied,
using the initial CT as a point of reference, to assess the
growth index of the haematoma in the nonsurvivor group as a
novel approach. To the best of our knowledge, no remarkable
previous attempts have been made to use this method on
cadaver brains with ICH.
Furthermore, we developed a new scoring system to
predict the risk of death within 30 days after primary supra-
tentorial ICH using variables found to be independently and
significantly associated with outcome by multiple logistic
regression analysis. All of these variables can practically be
reported within the first few hours after admission. After
validation, this scoring system has the potential to be useful
for early classification of patients.
2. Subjects and Methods
2.1. Patient Population. Ethical permission for these investi-
gations was granted by the Regional and Institutional Ethics
Committee, University of Debrecen, Medical and Health
Science Center. We retrospectively reviewed the data of 156
Caucasian patients (71 nonsurvivors and 85 survivors) with
primary supratentorial ICH admitted to our Intensive Care
Unit (ICU) in a 53-month period.Theoutcomewas defined as
30-day fatality for any reason. All patients were older than 18
years of age and were transported to our ICUwithin 24 hours
of stroke onset. If this point of time could not be ascertained,
we used the last time when the patient was known to be well.
All patients routinely underwent a baseline nonenhanced CT
within 30 minutes of arrival, and the CT confirmed the ICH.
A second CT was obtained on average on the 10th day after
admission orwhen symptoms deteriorated. Exclusion criteria
were traumatic ICH, subarachnoid haemorrhage (SAH), vas-
cular malformation, tumour, haemorrhagic transformation
of ischaemic stroke (on admission or any CT performed
later), postthrombolytic haemorrhage in ischaemic stroke,
infratentorial ICH, and primary intraventricular bleeding.
We did not include subjects who had undergone neurosur-
gical evacuation or drainage. All patients were treated on
specialized stroke units with multiparametric monitoring.
2.2. Data Collection. The following data were collected ret-
rospectively from patients’ clinical notes partly based on the
Debrecen Stroke Database [11, 12]: sex, age, current smok-
ing, excessive alcohol consumption, systolic and diastolic
arterial blood pressure, and pulse rate at arrival. Laboratory
parameters were collected from the initial blood sampling:
serum sodium, potassium, glucose levels, sedimentation rate,
haemoglobin, white blood cell (WBC) and platelet counts,
liver and kidney function tests, and coagulation parameters.
2.3. CT Analysis. Image analysis was carried out retrospec-
tively by two consultant neuroradiologists of our Department
of Biomedical Laboratory and Imaging Science, who were
blinded to the outcome. CT scans were performed on two 16-
sliceMDCT (multidetector computed tomography) scanners
(GE CT/e Dual, GE Lightspeed 16; GE Medical Systems).
Slice thickness was 5 to 10mms for supratentorial and 2.5
to 4mms for infratentorial regions. Images were transferred
to an offline image processing workstation as DICOM
(Digital Imaging and Communications in Medicine) files.
Haemorrhage segmentation was carried out using the 3D
Slicer software package developed by Brigham and Women’s
Hospital Surgical Planning Laboratory and MIT (Boston,
Massachusetts, USA) [13]. This procedure allowed separa-
tion of the intracranial space from the skull and nonbrain
structures; however, this method required verification and
manual detachment of incorrectly labelled areas before per-
forming volumetry with the built-in “Measurevol” module.
The following variables were constructed: total intracra-
nial volume; total haematoma volume; intraparenchymal
haematoma volume; and intraventricular haematoma vol-
ume, each expressed as cm3. Additionally, relative volumes
were defined as the ratio of total, intraparenchymal, and
intraventricular haematoma volumes to intracranial volume
yielding variables (without unit).
2.4. Neuropathological Analysis. Autopsies were performed
within 48 hours after death. In our Neuropathology Labora-
tory, brains fixed in 10% formalin were cut into coronal slices.
During the examination we verified the clinical diagnosis.
Similarly to the in vivo diagnostic the ABC/2 method was
used to estimate haematoma volumes [14, 15] based on the
assumption that the volume of an intracranial haematoma
can be approximated by an ellipsoid unless the haematoma is
very irregular in shape. Ellipsoids can be described in terms of
Cartesian coordinates using their three largest perpendicular
axes [16]. Consecutive coronal slices were laid down with
the posterior surface up, and maximal diameters of the
haematoma on every slice were measured in mms: one in
the horizontal direction and another perpendicular to that.
These two largest diameters were used as A and B in the
ABC/2 formula and were not necessarily on the same brain
slice; each slice has been photo documented. Although slices
were originally 10mms thick, we measured the thickness of
each slice at four different locations assuming that the brains
may have shrunk during fixation. The precise thickness of
a slice was obtained as the average of these measurements.
The resulting numerical data were then summed to obtain the
maximum diameter of the haematoma perpendicular to the
previous ones, which was used as C in the ABC/2 formula.
In cases when the haematoma did not fully penetrate a slice,
that is, the first and last brain slice containing the bleeding,
we measured the depth of the portion of haematoma by
sticking a probe into it. Due to fixation in formalin and brain
slicing in cases of ventricular extension it was not always
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Table 1: Summary of epidemiological and clinical data.
Characteristic Survivors Nonsurvivors 𝑃
Age∗ 65.3 (11.83) 69.2 (13.48) 0.054
Male (%) 57.6 52.5 0.593
Alcohol (%) 34.8 23.7 0.462
Smoking (%) 25.8 18.7 0.303
Systolic blood pressure (mmHg) 168.6 (32.93) 181.6 (34.86) 0.036
Diastolic blood pressure (mmHg) 93.8 (17.85) 95.3 (18.53) 0.627
Haemoglobin (g/L) 140.0 (16.55) 137.5 (17.61) 0.408
WBCs (109/L)∗ 9.5 (3.39) 9.3 (4.07) 0.292
Platelets (109/L) 236.1 (87.34) 205.9 (77.31) 0.049
Glucose (mmol/L) 7.4 (2.86) 8.9 (4.64) 0.043
Potassium (mmol/L)∗ 4.1 (0.35) 4.0 (0.57) <0.0001
The relationship between fatal outcomewithin 30 days and some selected discrete or continuous clinical variables. Age, sex, alcohol consumption, smoking, and
pulse rate at admission were not significantly associated with mortality. High systolic blood pressure, abnormal serum potassium concentration, high serum
glucose concentration, and lower platelet count at admission were predictors of lethal outcome. Serum potassium differences between survivors and deceased
subjects did not manifest as different group mean levels because the latter group was a mixture of many hypo- and hyperkalaemic subjects whose values
averaged out at a near normokalaemic level. WBC: white blood cell. Values are expressed as mean (SD) or percentages. ∗𝑃 value is from logistic regression
including quadratic term.
exactly discernible which part of the haematoma was in the
parenchyma and in the ventricles, respectively. Therefore the
haematoma volume calculated by the ABC/2 method was
equal to the sumof the intraparenchymal and intraventricular
parts. Volumes of haemorrhages were converted from mm3
to cm3. In these cases the relative haematoma volume was
calculated using the initial CT intracranial volumetry data
(for methods see above).
2.5. Statistical Analysis. The growth index of haematomas
was calculated in two steps according to the following logistic
formulas (log indicates natural logarithm): 𝐿 = log(hpb2/(1−
hpb2)) − log(hpb1/(1 − hpb1)), and growth index =
exp(𝐿)/(1 + exp(𝐿)) − 0.5, where hpb is haematoma per
brain; hpb2 is ratio of total haematoma volume obtained by
the second volumetry (follow-up CT scan in survivors, neu-
ropathological ABC/2 method in nonsurvivors) to intracra-
nial volume based on the follow-upCT (survivors) or the first
CT (nonsurvivors); hpb1 is ratio of total haematoma volume
to intracranial volume based on the first CT volumetry (sur-
vivors and nonsurvivors). Negative growth indices denote
reduction of haematoma; positive growth indices denote
haematoma expansion.
Variables were described using mean and SD (contin-
uous variables) or category percentages (categorical vari-
ables) stratified for survivors and nonsurvivors. Associations
between explanatory factors and the outcome of death within
30 days were evaluated using logistic regression. Curvatures
in relationships were assessed and allowed for by transfor-
mation or by adding a squared term if this substantially
improved model fit. Variables showing remarkable asso-
ciations in unadjusted models were selected for multiple
regressionmodeling unless they are collinear with each other,
in which case elimination was carried out on grounds of
clinical practicability. Left-out variables were assessed for
their potential contribution by adding to the prefinalmultiple
model one by one and left in if found clinically remarkable or
statistically significant. The final multiple logistic regression
model was checked for goodness of fit using the Hosmer-
Lemeshow test. The level of significance was set at 𝑃 = 0.05.
To create the scoring system,model-predicted probabilities of
outcome were generated for all subjects, and statistics for the
minimum, the 10th, 20th, . . ., 90th percentage points, and the
maximum were derived from the resulting set of values. The
coefficients of the final model were built into a spreadsheet-
based calculation interface which places any patient, with
given input data, in terms of probability-of-death percentage
range, given the percentage points observed on our sample of
patients. All analyses were performed using Stata Statistical
Software (StataCorp. 2009).
3. Results
Of the 81 survivor patients, eight were excluded because they
did not have a second CT. Of the 75 nonsurvivor patients
we excluded two based on brain autopsy results: ruptured
aneurysm of the middle cerebral artery and a metastatic
tumour, respectively, had been confirmed. Twelve brains
were unsuitable for volumetry due to fragmented, multilobar
haematomas or having been damaged during removal from
the skull, cases in which the ABC/2method fails to accurately
estimate haemorrhage volumes [17]. In addition, medical
records were not sufficiently detailed in a total of nine cases.
Thus, we analyzed the complete dataset of 59 nonsurvivor and
66 survivor patients.
The relationship between fatal outcome within 30 days
and some selected discrete or continuous clinical variables is
presented in Table 1.The relationship between age and greater
odds of death was of borderline significance. Other variables,
including sex, alcohol consumption, smoking, and pulse rate
at admission, were not significantly associated withmortality.
Higher systolic blood pressure at admission was a predictor
of lethal outcome.
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Table 2: Baseline CT data.
Characteristic Survivors Nonsurvivors P
Time from ictus to initial CT, hours 6.6 (7.3) 2.8 (2.6) 0.004
Total haematoma volume, cm3 16.3 (17.6) 57.8 (41.8) <0.0001
Intraparenchymal haematoma volume, cm3 12.8 (14.2) 38.6 (30.6) <0.0001
Intraventricular haematoma volume, cm3 3.6 (11.1) 19.2 (27.9) 0.002
Presence of intraventricular blood (%) 24.2 61.0 <0.0001
Relative total haematoma volume 0.012 (0.013) 0.043 (0.032) <0.0001
Relative intraparenchymal haematoma volume 0.009 (0.010) 0.029 (0.023) <0.0001
Haematoma growth index −0.2 (0.16) 0.1 (0.18) <0.0001
Differences in CT characteristics of survivors and nonsurvivors. The mean time from symptom onset to initial CT, growth index of haematoma volumes of
total and intraparenchymal haematoma on baseline CT, and the early presence of intraventricular haemorrhage and its volume were strongly associated with
fatal outcome. Values are expressed as mean (SD) or percentages.
Table 3: Total and relative haematoma volumes.
Characteristic Survivors Nonsurvivors
Baseline CT Follow-up CT Baseline CT Pathology
Total haematoma volume, cm3 16.3 (17.6) 9.3 (11.2) 57.8 (41.8) 89.0 (56.45)
Relative total haematoma volume 0.012 (0.013) 0.007 (0.008) 0.043 (0.032) 0.067 (0.042)
Presence of intraventricular blood (%) 24.2 9.1 61.0 88.1
Differences in volumetric findings of survivors and nonsurvivors. Intraventricular extension of the haematoma was more frequent in the nonsurvivor group
both on initial CT and on follow-up examinations. Relative volumes were defined as the ratio of total (intraparenchymal and intraventricular) haematoma
volume to intracranial volume yielding unitless variables. Values are mean (SD).
There was no statistical significance regarding sex, cur-
rent smoking, excessive alcohol consumption, diastolic arte-
rial blood pressure, and pulse rate at arrival. Laboratory
parameters were collected from the initial blood sampling:
serum sodium, potassium, glucose levels, sedimentation rate,
haemoglobin, white blood cell (WBC) and platelet counts,
liver and kidney function tests, and coagulation parameters.
Of these, serum potassium concentration was significantly
associated with fatal outcome: high and low levels outside
the normal range both represented elevated odds of death.
We identified higher serum glucose concentration and lower
platelet count as further predictors of fatal outcome.
Tables 2 and 3 summarize the differences in CT charac-
teristics and volumetric findings between survivors and non-
survivors. The mean time from symptom onset to initial
CT was strongly and inversely related to occurrence of
death within 30 days. In the survivor group, the mean
time between baseline and second CT was 10.7 (SD 5.05)
days; in the nonsurvivor group, the mean time between
symptom onset and death was 7.7 (SD 6.4) days. Differences
between the two groups in absolute volumes of total and
intraparenchymal haematoma on baseline CT were strongly
significant, similarly to relative haematoma volumes. The
growth index of haematoma was found to be a very strong
predictor of the outcome. The early presence of intraventric-
ular haemorrhage and its volumewas also strongly associated
with fatal outcome. There was an approximate 43% decrease
in the mean volume of total haemorrhage from baseline to
follow-up CT in survivors and a 54% increase from initial CT
to death in the other group and, consistently, there was a 42%
decrease in survivors and a 56% increase in nonsurvivors in
relative total haematoma volume. Intraventricular extension
of the haematoma was more frequent in the nonsurvivor
group both on initial CT and on follow-up examinations.
3.1. The SUSPEKT Scoring System. The final multiple logistic
regression model showed statistically significant associations
between 30-day case fatality and a number of variables: serum
glucose (Sugar); total haematoma volume (Size); systolic
blood Pressure; presence of intraventricular haemorrhage
(Extension to the ventricular system); and serum potassium
level (Kalium). Using these and adding age (lifeTime) which
was of borderline significance we developed the six-factor
scoring system SUSPEKT. The SUSPEKT scoring system in
use to make predictions after primary supratentorial ICH is
demonstrated in Tables 4 and 5. Values of 𝑥 represent means
observed in the present study, hence the decimal fraction for
intraventricular haemorrhage; 𝑒 denotes Euler’s number.
4. Discussion
Predictors of fatal outcome in primary ICH have been widely
studied [6, 18–24]. However no reliable and widely used
scoring system has been established as yet. Our aim was to
assess a relatively simple, reproducible, cost-effective predic-
tive scoring system by analysis of a wide range of clinical
and epidemiological data. Our results show that systolic
blood pressure, serum potassium and glucose levels, and
platelet count independently and statistically significantly
predict the 30-day fatal outcome in primary supratentorial
ICH. Therefore, we propose a predictive scoring system for
clinical outcome in ICHusing six parameters (serum glucose;
total haematoma volume; systolic blood pressure; presence
of intraventricular haemorrhage; serum potassium level; and
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Table 4: Example 1 for the use of SUSPEKT score.
Factor Value in patient (𝑥) Coefficient (𝑏) Multiply 𝑏 by 𝑥 (𝑏𝑥)
SU: serum glucose (mmol/L) 8.097 0.105504 0.854244
𝑆: relative total haematoma volume 0.027 68.94767 1.845598
𝑃: admission systolic BP (mmHg) 174.728 0.003043 0.53161
𝐸: intraventricular blood (no = 0, yes = 1) 0.416 0.441198 0.183538
𝐾: serum potassium (mmol/L) 4.054 −19.2919 −78.2126
Serum potassium squared ([mmol/L]2) 16.436 2.329607 38.28992
𝑇: age (years) 67.168 0.040057 2.690528
Constant term 1 33.54228 33.54228
Calculate by summing all 𝑏𝑥 values → −0.2749 = sbx
Use the formula 𝑒𝑠𝑏𝑥/(1 + 𝑒𝑠𝑏𝑥) → 0.431706 = pr
The final multiple logistic regression model showed statistically significant associations with 30-day case fatality for a number of variables. An example of the
SUSPEKT scoring system is presented. Values of 𝑥 represent means observed in the present study, hence the decimal fraction for intraventricular haemorrhage;
𝑒 denotes Euler’s number. Enter patient’s values and derive probability (pr) using the coefficients and follow the instructions.
Table 5: Example 1 for the use of SUSPEKT score.
0.036732 Minimum
0.095083 10th percentile
0.133933 20th percentile
0.190302 30th percentile
0.263309 40th percentile
0.376832 50th percentile
0.516875 60th percentile
0.769061 70th percentile
0.918411 80th percentile
0.975373 90th percentile
0.999965 Maximum
Table 5 illustrates a working example of the SUSPEKT scoring system.
Refer pr (probability) (0.432, see Table 4) to the table: patient is between the
50th and 60th percentiles of the SUSPEKT learning dataset for probability of
death.
age) with the acronym SUSPEKT. In the subsequent para-
graphs we discuss the individual components of SUSPEKT
score and some of the other analyzed candidate parameters
which did not show significant correlation with outcome
prediction.
Of the laboratory parameters, we found serum glucose
(SU) level on admission to be significantly associated with
lethal outcome and this result is also supported by previ-
ous studies [25, 26], while others reported that, in ICH,
hyperglycaemia is not a significant and independent outcome
predictor [6, 18, 27]. Recently Lee et al. confirmed in stroke
patients by magnetic resonance imaging and spectroscopy
study that acute hyperglycaemia adversely affects stroke
outcome [28].
We also found that absolute and relative haematoma vol-
umes (“S” for size), haematoma growth index, and presence
and size of intraventricular haemorrhage are predictors of
death within 30 days after ICH. We recommend the use of
absolute haematoma volume since it is easier to calculate and
its predictive value is similar to relative volume. Haematoma
volume is a well-known essential predictor of outcome in
patients with ICH [5, 6, 18–20, 29–33].
According to previous findings, high systolic [34] and
mean arterial [27] blood pressure (P) on admission are asso-
ciated with outcome, and admission diastolic blood pressure
is associated with larger ICH volume [35].We found only sys-
tolic blood pressure to strongly predict 30-day fatal outcome.
Presence and size of intraventricular haemorrhage (“E”
for expansion) are also strongly associated with outcome
in both overall and supratentorial cerebral haemorrhages
[18, 20, 21, 26, 36, 37]. Haematoma expansion is a strong
determinant of both mortality and poor functional outcome
after ICH [7]. Brott et al. found a trend toward higher
mortality at 4 weeks in patients with haemorrhage growth
[38].
We observed a previously unreported, very strongly sig-
nificant association between serumpotassium (“K”) level and
30-day lethal outcome, which was related to both high and
low levels outside the normal range, although others found
that higher dietary potassium intake is associated with lower
rates of stroke [39]. Similar (clinicopathological) observation
has been published earlier by our group on patients with
haemorrhagic transformation [40].
Our result could be explained by the fact that high
and low potassium levels are associated with morbidity and
mortality also through cardiac effects: ventricular fibrillation
and cardiac arrest. At extreme serum potassium levels death
probably occurred because of cardiac dysfunction and not
directly due to intracranial mass effect.
Age (“T” for lifetime) had a borderline predictive 𝑃 value
of 0.054 consistent with previous observations that the role
of age in outcome after ICH is controversial. Some prior
studies reported that age was significantly and independently
correlated with fatal outcome, while others did not find this
association [5–7, 18–20, 29–31, 41] or only for patients aged
≥80 years [6].We found that the relationship between age and
death within 30 days is of borderline significance.
We identified low platelet count as a predictor of fatal
outcome and it is also reported that low platelet count and
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platelet dysfunction significantly correlate with haematoma
growth [42]. Low haemoglobin showed no association with
lethal outcome within 30 days. Although Kumar et al. [35]
reported that anaemia and WBC count were associated with
larger haematomas, none of these variables were predictors of
30-day mortality in concert with our results.
Time from symptom onset to initial CT was inversely
and strongly associated with fatal outcome. This paradoxical
relationship could be explained by cases of rapidly worsening
complaints or severe signs caused by massive haemorrhages
having presented to hospital sooner and, in contrast, slower
response by patients experiencing mild impairment due to
small haemorrhages.
There was no correlation between smoking and 30-day
mortality. In a Japanese study smoking was an independent
risk factor for death in both the ischaemic and haemorrhagic
stroke [36], while other reports found no association [31, 37,
43]. Ikehara et al. reported that heavy alcohol consumption
is significantly associated with increased mortality from
haemorrhagic stroke for men [44]; however, in the present
study we found no association between alcohol consumption
and fatal outcome in ICH, which is in accordance with the
results of Hansagi et al. [45].
Several prognosticmodels have been developed to predict
fatal outcome after ICH, the most reliable and simplest being
the ICH score by Hemphill et al. [6, 19, 22–24]. Prognostic
scores limited to supratentorial haemorrhages are also known
[18, 20, 21]. These studies focused on several factors: age
[6, 19, 20, 22], sex [20], level of consciousness (GCS, NIHSS
consciousness score) [6, 18, 19, 22], volume or location
of haemorrhage [6, 18–20, 23], presence of intraventricu-
lar haemorrhage [6, 18–21, 24], presence of hydrocephalus
on initial computed tomography scan [23], subarachnoid
extension of haemorrhage [24], high NIHSS total score [22,
24], focal neurological deficit on admission [23], and pulse
pressure [6, 24] were predictors of poor clinical prognosis;
low temperature at admission and lowNIHSS total scorewere
predictors of good clinical outcome (modifiedRankin score≤
2) [24]. Compared with the previously used prognostic score,
undoubtable forcefulness of SUSPEKT score is that it includes
serum potassium level which is a novelty and hyperglycaemia
which can be corrected [2]. Another advantage of our scoring
system is that it consists of only 6 parameters and except
haematoma volume these can be managed and influenced by
conservative (i.e., nonsurgical) therapeutic interventions.
Early prognostication after ICH is riddled with uncer-
tainties. Given this and the self-fulfilling pessimistic general
opinion of poor outcome, reliable early prognostication after
ICH can help to avoid a fatalistic approach by the wider care
team including family members and enables evidence based
DNR (do not resuscitate) orders.Thus, deliberated guideline-
concordant therapy is essential for all ICH patients [2]. Early
prognostication helps clinicians to reach an objective opinion
of predictable outcome.
Our findings are limited by some shortcomings. Prehos-
pital deaths, exclusion of large, multilobar haematomas, and
missing second CT in the survivor group may have led to
possible selection bias.
5. Conclusion
We have demonstrated that systolic blood pressure, serum
potassium and glucose levels, platelet count, absolute and
relative haematoma volumes, haematoma growth index, and
presence and size of intraventricular haemorrhage indepen-
dently predict 30-day fatal outcome in primary supratentorial
ICH. We developed the SUSPEKT score which after vali-
dation on large independent datasets may be applicable in
clinical practice for patient selection to optimize individual
management and for assessment of eligibility for clinical
trials.
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